Cyted Health
We are redefining digestive health by pioneering non-endoscopic diagnostics, enabling early detection of diseases and access to care for everyone, everywhere.
Cyted Health has raised €37M across 1 funding round from 5 investors, most recently a Series B round in Sep 2025. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.
Cambridge, UKcytedhealth.com ↗
Total raised
€37M
€37,347,736
Funding rounds
1
Investors
5
distinct backers
Active since
2025-09
latest 2025-09
Funding by year
EUR raised per yearCyted Health — funding by year — interactive chart.
Data table
| Cyted Health — funding by year | |
|---|---|
| 2025 | €37M |
Signals
High confidenceRaise-next likelihood65
base rate 48% for Series B
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-02 | Series B | €37M | Advent Life Sciences,BGF,British Business Bank,EQT Life Sciences,Morningside Ventures | View deal → |